Pediatric dermatology
-
Pediatric dermatology · Nov 2015
Deficiencies in Dermatologic Training in Pediatric Residency: Perspective of Pediatric Residency Program Directors.
Children with skin-related problems commonly present to general pediatricians, and dermatology is among the top specialty areas that pediatricians have identified as having inadequate training to support their practice. This study was designed to document current opportunities for dermatologic training during pediatric residency and provides suggestions for improvement. ⋯ Exposure to dermatology clinics was perceived to be the most desirable training modality for pediatric residents, but a minority of residents receive this exposure. Many pediatric residency program directors felt that residents receive inadequate dermatology training, which indicates a need to address educational deficiencies. Supporting a pediatric dermatologist on staff and requiring a rotation in pediatric dermatology could improve dermatologic curricula for pediatric residents.
-
Pediatric dermatology · Sep 2015
Multicenter Study Controlled Clinical TrialA Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.
To evaluate the efficacy and safety of onabotulinumtoxinA in adolescents with primary axillary hyperhidrosis. ⋯ OnabotulinumtoxinA injections provided beneficial effects in adolescents with primary axillary hyperhidrosis.
-
Androgen hormones are thought to play a leading role in acne vulgaris (AV). The 2D:4D digit ratio refers to the ratio of the length of the second finger (index finger) to that of the fourth finger (ring finger). It is thought that the balance between fetal testosterone and fetal estrogen during the prenatal period largely determines this ratio, which does not change with age in the postnatal period. ⋯ The 2D:4D ratio was not significantly different between the group with AV and the control group independent of sex. Also, we did not observe a significant association with age of onset, severity of disease, or family history.
-
Pediatric dermatology · May 2015
Pediatric dermatology training during residency: a survey of the 2014 graduating residents.
Knowledge of pediatric dermatology is considered a core competency of dermatology training and should be expected of all practicing dermatologists. While the numbers of both pediatric dermatology fellowships and board certified pediatric dermatologists in the workforce have increased over the years, recent reports suggest that there is a gap in pediatric dermatology education during dermatology residency. The goal of this study is to assess the current state of pediatric education during residency, as well as the clinical experience, satisfaction and expectations of graduating dermatology residents. ⋯ This survey highlights a promising state of pediatric dermatology training among current graduating dermatology residents. The majority of current graduating dermatology residents are satisfied with their pediatric dermatology education, feel confident treating pediatric patients, and plan to see pediatric patients in clinical practice.
-
Pediatric dermatology · Mar 2015
Comparative StudyOutpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Oral and topical β-blockers are used to treat infantile hemangiomas (IHs). Although a recent consensus report provided guidelines for the treatment of IH with propranolol, there are no standard guidelines for the use of topical timolol. The objectives of this study were to determine the current use of oral propranolol and topical timolol by pediatric dermatologists in an outpatient setting and to compare current propranolol use with published propranolol consensus guidelines. ⋯ The most common indication was superficial hemangiomas (97%). Most practitioners (74%) did not routinely monitor heart rate or blood pressure in infants treated with topical timolol. This study highlights the variability in prescribing and monitoring practices of physicians using propranolol for the treatment of IHs and demonstrates that topical timolol is commonly used alone and in conjunction with oral propranolol to treat IHs.